Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei

被引:32
作者
Karvonen, U
Jänne, OA
Palvimo, JJ
机构
[1] Univ Helsinki, Inst Biomed, Biomedicum Helsinki, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Dept Clin Chem, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland
[4] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland
来源
FEBS LETTERS | 2002年 / 523卷 / 1-3期
基金
芬兰科学院;
关键词
androgen receptor; antiandrogen; coactivator; transcription; nucleus;
D O I
10.1016/S0014-5793(02)02929-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used confocal microscopy to elucidate the effects of antiandrogens on nuclear localization of the androgen receptor (AR) with its transcriptional coactivator GRIP1. We show that the agonist-activated AR recruits GRIP1 to colocalize with the receptor in the nucleoplasm. By contrast, AR complexed to the antiandrogens hydroxyflutamide and bicalutamide fails to influence nuclear distribution of GRIP1. Likewise, the non-steroidal antiandrogens prevent the agonist-induced AR-GRIP1 colocalization from occurring. Androgen antagonists affect nuclear redistribution of AR-GRIP1 in a fashion that parallels their effects on the transcriptional activity of AR, in that the pure antagonists block GRIP1-dependent activation of AR function, whereas the mixed antagonist/agonist cyproterone acetate promotes both AR-driven redistribution of GRIP1 and activation of AR by GRIP1. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:43 / 47
页数:5
相关论文
共 37 条
[1]  
Alen P, 1999, MOL CELL BIOL, V19, P6085
[2]   The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome [J].
Baumann, CT ;
Ma, H ;
Wolford, R ;
Reyes, JC ;
Maruvada, P ;
Lim, C ;
Yen, PM ;
Stallcup, MR ;
Hager, GL .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (04) :485-500
[3]   STEROID-HORMONE RECEPTORS - MANY ACTORS IN SEARCH OF A PLOT [J].
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G .
CELL, 1995, 83 (06) :851-857
[4]  
Bevan CL, 1999, MOL CELL BIOL, V19, P8383
[5]   Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor [J].
Doesburg, P ;
Kuil, CW ;
Berrevoets, CA ;
Steketee, K ;
Faber, PW ;
Mulder, E ;
Brinkmann, AO ;
Trapman, J .
BIOCHEMISTRY, 1997, 36 (05) :1052-1064
[6]   The amino terminus of the human AR is target for corepressor action and antihormone agonism [J].
Dotzlaw, H ;
Moehren, U ;
Mink, S ;
Cato, ACB ;
Lluhí, JAI ;
Baniahmad, A .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (04) :661-673
[7]   Functional architecture in the cell nucleus [J].
Dundr, M ;
Misteli, T .
BIOCHEMICAL JOURNAL, 2001, 356 (02) :297-310
[8]  
Gregory CW, 2001, CANCER RES, V61, P4315
[9]   FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor [J].
He, B ;
Kemppainen, JA ;
Wilson, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :22986-22994
[10]   Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain [J].
He, B ;
Kemppainen, JA ;
Voegel, JJ ;
Gronemeyer, H ;
Wilson, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) :37219-37225